Edward Chait is listed as a director on 2 SEC Form D filings by 1 issuer between Jul 2014 and Nov 2014: Empire Genomics, LLC (Buffalo, NY — other health care — 2014; $1.25M reported sold to 4 investors).
What this means One deal on file with the SEC, filed Nov 2014. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Anthony Johnson (2 shared filings), Daniel Penberthy (2 shared filings), Michael B. Sexton (2 shared filings) and Norma Nowak (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Edward. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Edward Chait and found 3 differences: Form D filed 26 days after the first sale; Offering amount changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.